|
|
|
15.04.25 - 17:48
|
SMAIO Announces Consolidated Results for 2024 and Record Sales Performance in Q1 2025 (Business Wire)
|
|
|
Sharp increase in sales, up +114%1 to €5.5 million in 2024 and +140% to €2.5 million in Q1 2025
Improvement in the margin rate on implant sales to 79% in 2024, vs. 71% at the end of 2023
EBITDA improvement of +33% (-€1.8 million in 2024 vs. -€2.61 million in 2023)
Solid cash position of €3.2 million at December 31, 2024
Signature of a letter of intent (LOI) for a €1.5 million capital increase at €3.60 per new share and a €1 million issue of convertible bonds (5-year maturity, conversion price of €4.50 per share), reserved for NextStage AM
DALLAS & LYON, France--(BUSINESS WIRE)--Regulatory News:
SMAIO (Paris:ALSMA):
Webconference in French today at 6 pm CEST:
REGISTER HERE
SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA), a French-American player specialized in complex spine surgery with a global offer comprising software, adaptative implants and related services, today published its consolidated 2024...
|
|
|
28.02.25 - 18:06
|
SMAIO Adds a New High-Profile Member to Its Scientific Advisory Board in the United States (Business Wire)
|
|
|
Appointment of Dr. Donald J. Blaskiewicz, neurosurgeon at St. Luke's Clinic in Boise (Idaho)
SMAIO's U.S. scientific advisory board now includes three North American surgeons, and is set to support the Company's expansion in the largest spine market in the world
DALLAS & LYON, France--(BUSINESS WIRE)--Regulatory News:
SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA), a French-American player specialized in complex spine surgery with a global offer comprising software, adaptative implants and related services, today announced the appointment of Dr. Donald J. Blaskiewicz, neurosurgeon at St. Luke's Clinic in Boise (Idaho) to its recently created U.S. scientific advisory board.
In mid-October 2024, SMAIO announced the creation of a U.S. scientific advisory board with the appointment of its two founding members, Dr. Brian Neuman (orthopedic surgeon) and Dr. Camilo Molina (neurosurgeon), both practicing at the Washington Univer...
|
|
|
21.01.25 - 18:03
|
SMAIO Announces 2024 Sales of €5.5m, More Than Half of Which Generated in the United States (Business Wire)
|
|
|
Implant sales growth in excess of 100%, thanks to a strategic focus on the US market, driving strong revenue growth which is now mainly generated in the United States
Establishment of the Group's sales and general management in the United States (Dallas, Texas), enabling 2024 sales to reach €2.9m in this strategic market, with a record fourth quarter at €1.5m.
8 user centers in the United States at end-2024 and advanced registration process in 5 additional centers, pointing to further sustained growth in 2025DALLAS & LYON, France--(BUSINESS WIRE)--Regulatory News:
SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris ISIN: FR0014005I80 / Ticker: ALSMA), a French-American player specialized in complex spine surgery with a global offer comprising software, adaptative implants and related services, today published its annual sales for the full year to December 31, 2024.
Philippe ROUSSOULY, Chairman and CEO of SMAIO, said: "The year 2024 marked a decisive turnin...
|
|
|
06.01.25 - 17:48
|
SMAIO: 2025 Financial Calendar (Business Wire)
|
|
|
LYON, France--(BUSINESS WIRE)--Regulatory News:
SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris ISIN: FR0014005I80 / Ticker: ALSMA, PEA-PME eligible), a French player specialized in complex spine surgery with a global offer comprising software, adaptative implants and related services, today announces its indicative financial calendar for 2025.
Events
Dates
2024 full-year revenue
Tuesday, January 21, 2025
2024 full-year results
Tuesday, April 15, 2025
Annual general meeting
Tuesday, June 17, 2025
2025 first-half revenue
Wednesday, July 16, 2025
2025 first-half results
Tuesday, October 14, 2025
This preliminary agenda may be modified. Each publication will be released after market close.
About SMAIO
A precursor in the use of clinical data and imaging of the spine, SMAIO designs global solutions for spine surgery specialists. The Company has recognized expertise thanks to KEOPS, its Big Data management software that has become a global reference with more than 100...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
